Game-changer on table as EU and US discuss simultaneous regulatory evaluation for medical devices
This article was originally published in SRA
Executive Summary
Will manufacturers be able to apply simultaneously for EU and US regulatory approvals for their medical devices in the near future, thereby cutting costs and time to market?